MS
DGX icon

Murray Stahl’s Quest Diagnostics DGX Stock Holding History

Murray Stahl’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615K Hold
2,900
– – 0.01% 202
2026
Q1 		$568K Sell
2,900
-100
-3% -$19.4K 0.01% 213
2025
Q4 		$521K Hold
3,000
– – 0.01% 221
2025
Q3 		$572K Sell
3,000
-2,100
-41% -$373K 0.01% 221
2025
Q2 		$916K Sell
5,100
-450
-8% -$78.2K 0.01% 186
2025
Q1 		$939K Sell
5,550
-50
-0.9% -$8.21K 0.01% 184
2024
Q4 		$845K Hold
5,600
– – 0.01% 194
2024
Q3 		$869K Buy
5,600
+1,050
+23% +$157K 0.01% 192
2024
Q2 		$623K Hold
4,550
– – 0.01% 199
2024
Q1 		$606K Sell
4,550
-100
-2% -$13K 0.01% 202
2023
Q4 		$641K Hold
4,650
– – 0.01% 193
2023
Q3 		$567K Sell
4,650
-8
-0.2% -$1.07K 0.01% 203
2023
Q2 		$655K Buy
4,658
+8
+0.2% +$1.1K 0.01% 195
2023
Q1 		$658K Sell
4,650
-150
-3% -$21.5K 0.01% 192
2022
Q4 		$751K Hold
4,800
– – 0.01% 180
2022
Q3 		$589K Hold
4,800
– – 0.01% 197
2022
Q2 		$638K Hold
4,800
– – 0.01% 198
2022
Q1 		$657K Sell
4,800
-12
-0.2% -$1.67K 0.01% 211
2021
Q4 		$833K Sell
4,812
-50
-1% -$7.61K 0.02% 197
2021
Q3 		$706K Hold
4,862
– – 0.02% 212
2021
Q2 		$642K Buy
4,862
+50
+1% +$6.55K 0.01% 220
2021
Q1 		$618K Sell
4,812
-100
-2% -$12.3K 0.01% 221
2020
Q4 		$585K Hold
4,912
– – 0.02% 217
2020
Q3 		$562K Sell
4,912
-100
-2% -$11.8K 0.02% 228
2020
Q2 		$571K Buy
5,012
+12
+0.2% +$1.27K 0.02% 216
2020
Q1 		$402K Sell
5,000
-300
-6% -$31.1K 0.02% 236
2019
Q4 		$566K Hold
5,300
– – 0.02% 236
2019
Q3 		$567K Hold
5,300
– – 0.02% 242
2019
Q2 		$540K Hold
5,300
– – 0.01% 252
2019
Q1 		$477K Buy
+5,300
New +$459K 0.01% 263

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Murray Stahl's DGX Position: Q2 2026 in Review

Murray Stahl held its Quest Diagnostics (DGX) position steady in Q2 2026 at 2,900 shares worth $615K. The position accounts for 0.01% of the portfolio, ranked #202.

Murray Stahl first reported a position in DGX in Q1 2019 and has held it in 30 quarters since. The position peaked at $939K in Q1 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Murray Stahl held 2,900 shares of Quest Diagnostics worth $615K as of Q2 2026.
  • Murray Stahl left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of Murray Stahl's portfolio in Q2 2026, its #202 holding.
  • Murray Stahl first reported a position in Quest Diagnostics in Q1 2019 and has held it in 30 quarters since.
  • Murray Stahl's Quest Diagnostics position peaked at $939K in Q1 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.